Zimmer Biomet Holdings Inc (ZBH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 10.73 is considered Undervalued compared with the five-year average of 15.63. The fair price of Zimmer Biomet Holdings Inc (ZBH) is between 188.28 to 229.29 according to relative valuation method. Compared to the current price of 99.49 USD , Zimmer Biomet Holdings Inc By Undervalued By 47.16%.

Relative Value

Fair Zone

188.28-229.29

Current Price：99.49

47.16%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Zimmer Biomet Holdings Inc (ZBH) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Zimmer Biomet Holdings Inc (ZBH) has a current Price-to-Book (P/B) ratio of 1.40. Compared to its 3-year average P/B ratio of 1.84, the current P/B ratio is approximately -23.82% higher. Relative to its 5-year average P/B ratio of 2.00, the current P/B ratio is about -30.14% higher. Zimmer Biomet Holdings Inc (ZBH) has a Forward Free Cash Flow (FCF) yield of approximately 6.76%. Compared to its 3-year average FCF yield of 4.46%, the current FCF yield is approximately 51.51% lower. Relative to its 5-year average FCF yield of 4.13%, the current FCF yield is about 63.93% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ZBH competitors is 4.79, providing a benchmark for relative valuation. Zimmer Biomet Holdings Inc Corp (ZBH.N) exhibits a P/S ratio of 2.09, which is -56.41% above the industry average. Given its robust revenue growth of 10.90%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ZBH increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ZBH in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ZBH currently overvalued or undervalued?

Zimmer Biomet Holdings Inc (ZBH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 10.73 is considered Undervalued compared with the five-year average of 15.63. The fair price of Zimmer Biomet Holdings Inc (ZBH) is between 188.28 to 229.29 according to relative valuation method. Compared to the current price of 99.49 USD, Zimmer Biomet Holdings Inc is Undervalued By 47.16%.

What is Zimmer Biomet Holdings Inc (ZBH) fair value?

ZBH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Zimmer Biomet Holdings Inc (ZBH) is between 188.28 to 229.29 according to relative valuation method.

How does ZBH's valuation metrics compare to the industry average?

The average P/S ratio for ZBH's competitors is 4.79, providing a benchmark for relative valuation. Zimmer Biomet Holdings Inc Corp (ZBH) exhibits a P/S ratio of 2.09, which is -56.41% above the industry average. Given its robust revenue growth of 10.90%, this premium appears unsustainable.

What is the current P/B ratio for Zimmer Biomet Holdings Inc (ZBH) as of Mar 03 2026?

As of Mar 03 2026, Zimmer Biomet Holdings Inc (ZBH) has a P/B ratio of 1.40. This indicates that the market values ZBH at 1.40 times its book value.

What is the current FCF Yield for Zimmer Biomet Holdings Inc (ZBH) as of Mar 03 2026?

As of Mar 03 2026, Zimmer Biomet Holdings Inc (ZBH) has a FCF Yield of 6.76%. This means that for every dollar of Zimmer Biomet Holdings Inc's market capitalization, the company generates 6.76 cents in free cash flow.

What is the current Forward P/E ratio for Zimmer Biomet Holdings Inc (ZBH) as of Mar 03 2026?

As of Mar 03 2026, Zimmer Biomet Holdings Inc (ZBH) has a Forward P/E ratio of 10.73. This means the market is willing to pay $10.73 for every dollar of Zimmer Biomet Holdings Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Zimmer Biomet Holdings Inc (ZBH) as of Mar 03 2026?

As of Mar 03 2026, Zimmer Biomet Holdings Inc (ZBH) has a Forward P/S ratio of 2.09. This means the market is valuing ZBH at $2.09 for every dollar of expected revenue over the next 12 months.

ZBH Valuation